FDA Inspection 1044147 — John D. Gabriel, MD
The FDA completed an inspection of John D. Gabriel, MD on February 8, 2018 in North Richland Hills, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 8, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Richland Hills, TX (United States)
Additional Details
Clinical Investigator (CI)